ArticleCancer research2022

Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD-Driven AML.

Anamarija Pfeiffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.